CoreAge Rx vs Willow
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Willow head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Willow a bad call — it's best for people comparing treatment formats who will check the prescribed tier and renewal cutoff before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Willow |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $299/mo for listed standard injection tiers or sublingual tablet; higher injection tier listed at $399/mo |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | From $399/mo; listed injection tiers reach $549/mo and tablet tiers reach $459/mo |
| Coverage | US only; restrictions by state, confirmed at intake | 36 states listed by the provider; confirm your treatment and address |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Willow: Semaglutide is generally $299 per month, with a higher injection tier at $399; tirzepatide prices vary by formulation and dose. Check the prescribed tier and cancellation deadline before enrolling.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.